SCHEMBL3174564

SCHEMBL3174564

CC(=O)NCCNc1cc(N2CCN(C(=O)c3ccc(-c4ccccc4)cc3)CC2)nc(-c2ccc(Cl)cc2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 2/20 0.50
SLC6A7 Q99884 7/20 0.48
ALDH1A1 P00352 3/20 0.45
MAPK1 P28482 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
MGLL Q99685 2/20 0.45
TSHR P16473 1/20 0.44
SLC6A3 Q01959 1/20 0.44
USP2 O75604 1/20 0.44
CASP1 P29466 1/20 0.44
CASP7 P55210 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
KDM6B O15054 1/20 0.43
NR1I2 O75469 1/20 0.43
CHRNA1 P02708 1/20 0.43
MAOB P27338 1/20 0.43
OPRM1 P35372 1/20 0.43
AHR P35869 1/20 0.43
AVPR1A P37288 1/20 0.43
OPRK1 P41145 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3156444 0.96 GBA1 (0.46) GBA1SLC6A7ALDH1A1USP2CASP1
SCHEMBL3171321 0.95 GBA1 (0.54) GBA1SLC6A7ALDH1A1MAPK1L3MBTL1
SCHEMBL3176917 0.95 GBA1 (0.46) GBA1SLC6A7ALDH1A1USP2CASP1
SCHEMBL3174398 0.93 GBA1 (0.48) GBA1SLC6A7ALDH1A1MGLLSLC6A3
SCHEMBL3164315 0.92 GBA1 (0.50) GBA1SLC6A7ALDH1A1MGLLUSP2
SCHEMBL3175804 0.92 GBA1 (0.51) GBA1SLC6A7ALDH1A1MAPK1L3MBTL1
SCHEMBL3155347 0.92 GBA1 (0.49) GBA1SLC6A7ALDH1A1MAPK1L3MBTL1
SCHEMBL3164890 0.91 AKR1C3 (0.47) GBA1SLC6A7ALDH1A1SLC6A3USP2
SCHEMBL3166309 0.91 GBA1 (0.48) GBA1SLC6A7ALDH1A1MAPK1L3MBTL1
SCHEMBL3155558 0.90 SLC6A7 (0.47) GBA1SLC6A7ALDH1A1MAPK1MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed